A randomised double-blind , placebo-controlled , 24-week three centre trial of memantine ( 20mg/day ) was conducted in which tests of attention ( simple and choice reaction time ) and word recognition ( immediate and delayed ) from the CDR System were administered prior to dosing and again at 12 and 24weeks .